Aerosol therapy

Italian Journal of Pediatrics

Volumn 30, Issue 3, 2004, Pages 147-156

  Amirav, Israel ^a  

^a Rebecca Sieff Government Hospital   (Israel)

Author keywords

Aerosol; Children; Infants; Inhaled therapy; Nebulizers

Indexed keywords

BECLOMETASONE; BUDESONIDE; CHLOROFLUOROCARBON; CORTICOSTEROID; DRUG CARRIER; FLUORINATED HYDROCARBON; FORMOTEROL; LACTOSE; PROPELLANT; SALBUTAMOL; TECHNETIUM 99M; TERBUTALINE;

AEROSOL; AIRFLOW; CANDIDIASIS; CHILD HEALTH CARE; CRYING; CRYSTAL; DRUG DELIVERY SYSTEM; DRY POWDER; DRY POWDER INHALER; DYSPHONIA; FACE MASK; HUMAN; INFANT; JET NEBULIZER; LARYNX DISORDER; LUNG DISEASE; MEDICAL NEBULIZER; METERED DOSE INHALER; NEBULIZER; PARTICLE SIZE; PATIENT COMPLIANCE; PIEZOELECTRICITY; PRESCHOOL CHILD; PRESSURIZED METERED DOSE INHALER; RESPIRATORY SYSTEM; REVIEW; SMALL VOLUME LIQUID NEBULIZER; TASTE DISORDER; THRUSH; ULTRASONIC NEBULIZER; ULTRASOUND;

EID: 3543097982     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Zimet I. Respiratory pharmacology and therapeutics. Philadelphia: WB Saunders 1978:1-7.
2. Rubin BK, Fink JB. Aerosol therapy for children. Respir Care Clin North Am 2001:7:175-213.
3. Morrow PE. Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys 1966;12:173-207.
4. Morrow PE. Aerosol characterization and deposition. Am Rev Respir Dis 1974;110:88-99.
5. Everard ML, Le Souef PN. Aerosol therapy and delivery systems. In: Taussig L, Landau L, eds. Textbook of pediatric Respiratory Medicine. Mosby, St. Louis 1998.
6. Dolovich MB, Newhouse MT. Aerosols - Generation, methods of administration, and therapeutic applications in asthma. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice, 4th Edition. St. Louis: Mosby-Year Book, Inc. 1993, pp. 712-39.
7. Chua HL, Collis GG, Newbury AM, et al. The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7:2185-91.
8. Polgar G, Weng TR. The functional development of the respiratory system: from the period of gestation to adulthood. Am Rev Respir Dis 1979;120:625-9.
9. Johnson CE. Principles of nebulizer-derived drug therapy for asthma. Am J Hos Pharm 1989;46:1845-55.
10. Finlay WH, Stapelton KW, Zuberbuhler P. Comparison between inhaled fine particle fraction and lung dose for nebulized aerosols. J Aerosol Med 1998;11(Suppl 1):S65-S72.
11. Murakami G, Igarashi T, Adachi Y, Matsuno M, Adachi Y, Sawai M, et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy 1990;64:383-7.
12. Barnes KL, Clifford R, Holgate ST, Murphy D, Comber P, Bell E. Bacterial contamination of home nebulizers. Br Med J 1987;295:812.
13. Hollie MC, Malone RA, Skufca RM, Nelson HS. Extreme variabilty in aerosol output of the DeVilbiss jet nebulizer. Chest 1991;100:1339-44.
14. Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers: How reliable are they? Chest 1992;100:316-9.
15. Nikander K, Turpeinen M, Wollmer P. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med 1999;12:47-53.
16. O'Callaghan C, Barry PW. The science of nebulized drug delivery. Thorax 1997;52:(Suppl 2)S31-S44.
17. Newnham DM, Lipworth BJ. Nebulizer performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebulizer system (Ventstream). Thorax 1994;49:762-70.
18. Verdun AM, Mitchell JP, Nagel MW. Performance of a new breath-actuated small volume nebulizer (BA-SVN) when used with oxygen as driving gas under conditions of hospital use. Am J Respir Crit Care med 1998;157:A638.
19. 1 and FEF 25-75%. Eur Respir J 1998;12(Suppl 28):61S.
20. Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone diproprionate delivered by metered-dose inhaler alone and with AeroChamber. J Allergy Clin Immunol 1988;81:424-8.
21. Newhouse MT. Asthma therapy with aerosols: Are nebulizers obsolete? A continuing controversy. J Pediatr 1999;135:5-8.
22. Corr D, Dolovich M, McCormack D, Ruffin R, Obminski G, Newhouse M. Design and characteristics of a portable breath actuated, particle size selective medical aerosol inhaler. J Aerosol Sci 1982;13:1-7.
23. Chua HL, Chambers CB, Newhouse MT. Comparison of the effect of four MDI add-on devices on lung deposition and function in asthmatics. Am Rev Respir Dis 1994;149:A217.
24. Wildhaber JH, Devadason SG, Hayden MJ, Eber E, Summers QA, LeSouef PN. Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers. Pediatr Pulmonol 1997;23:212-6.
25. König P, Gayer D, Kantak A, Kreutz C, Douglass B, Hordvik NL. A trial of metaproterenol by metered-dose inhaler and two spacers in preschool asthmatics. Pediatr Pulmonol 1988;5:247-51.
26. Crimi N, Palermo F, Cacopardo B, Vancheri C, Oliveri R, Palermo B, et al. Bronchodilator effect of Aerochamber and Inspirease in comparison with metered dose inhaler. Eur J Respir Dis 1987;71:153-7.
27. Everard ML, Clark AR, Milner AD. Drug delivery from holding chambers with attached facemask. Arch Dis Child 1992;67:580-5.
28. Campbell R, Dolovich M, Chambers C, Newhouse M. Holding chamber volume/salbutamol dose delivered through an endotracheal tube at low tidal volumes. J Aerosol Med 1992;5:304.
29. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediarics 2001;108:389-94.
30. Bisgaard H. A metal aerosol holding chamber devised for young children with asthma. Eur Respir J 1995;8:856-60.
31. Bisgaard H, Anhoj J, Klug B, Berg E. A non-electrostatic spacer for aerosol delivery. Arch Dis Child 1995;73:226-30.
32. Pierart F, Wildhaber JH, Vrancken I, Devadason SG, Le Souef PN. Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J 1999;13:673-8.
33. Amirav I, Newhouse MT. Treatment failures in children with asthma due to inappropriate use of Turbuhaler. J Pediatrics 2002;140:483.
34. Kesten S, Elias M, Cartier A, Chapman KR. Patient handling of a multidose dry powder inhalation device for albuterol. Chest 1994;105:1077-81.
35. Meakin BJ, Cainey JM, Woodcock PM. Simulated in-use and mis-use aspects of the delivery of terbutaline sulphate from Bricanyl Turbohaler dry powder inhalers. Intern J Pharmaceut 1995;119:103-8.
36. Tseng M, Kennedy A, Chambers C, Newhouse MT. Bricanyl turbuhaler: High relative humidity and low inspiratory flow cause severe impairment of terbutaline deaggregation. Am J Resp Crit Care Med 1999;159:A117.
37. Newhouse M, Kennedy A, Tseng M, Stepner N. Ventolin Discus vs Inspiryl Turbuhaler under conditions of varying flow and relative humidity. Am J Resp Crit Care Med 1999;159:A117.
38. Everard ML, Devadason SG, Le Souef PN. Flow early in the inspiratory manoeuvre affects the aerosol particle size distribution from a Turbuhaler. Respir Med 1997;91:624-8.
39. Bisgaard H. Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer. Am J Respir Crit Care Med 1998;157:518-21.
40. Everard ML, Clark AR, Milner AD. Drug delivery from jet nebulisers. Arch Dis Child 1992;67:586-91.
41. Hayden JT, Smith N, Woolf DA, Barry PW, O'Callaghan C. A randomised crossover trial of facemask efficacy. Arch Dis Child 2004;89:72-3.
42. Everard ML. Inhalation therapy for infants. Adv Drug Deliv Rev 2003;55:869-78.
43. Janssens HM, Devadason SG, Hop WC, LeSouef PN, De Jongste JC, Tiddens HA. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J 1999;13:787-91.
44. Amirav I, Mansour Y, Mandelberg A, Bar-Ilan I, Newhouse MT. Redesigned face mask improves "real life" aerosol delivery for Nebuchamber. Pediatr Pulmonol 2004;37:172-7.
45. Mandelberg A, Tsehori S, Houri S, Gilad E, Morag B, Priel IE. Is nebulized aerosol treatment necessary in the pediatric emergency department? Chest 2000;117:1309-13.
46. Esposito-Festen JE, Bahar A, van Vliet FJM, Hop WCJ, Tiddens .HAWM. Aerosol delivery to young children: the relative importance of the facemask. ERS 2003, p. 1983.
47. Everard ML. Trying to deliver aerosols to upset children is a thankless task. Arch Dis Child 2000;82:428.
48. Ritson S, Everard ML, Denyer J, Prince I. Comparison of carers ability to use aerosol delivery systems in young children. ATS 2001.
49. Margot C, Couderc L, Le Roux P, Jeannot E, Lefay V, Mallet E. Inhalation treatment: Errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children. Pediatr Allergy Immunol 2001;12:224-30.
50. Tal A, Golan H, Grauer N, Aviram M, Albin D, Quastral MR. Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr 1996;128:479-84.
51. Murakami G, Igarashi T, Adachi Y, Matsuno M, Adachi Y, Sawai M, et al. Measurement of bronchial hyperreactivity in infants and preschool children using a new method. Ann Allergy 1990;64:383-7.
52. Wildhaber JH, Dore ND, Wilson JM, Devadason SG, LeSouef PN. Inhalation therapy in asthma; Nebuliser or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr 1999;135:28-33.
53. Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child 1999;81:163-5.
54. Amirav I, Balanov I, Gorenberg M, Groshar D, Luder AS. Nebulizer Hood Compared to Mask in Wheezy Infants: Aerosol Therapy Without Tears! Arch Dis Child 2003;88:719-23.
55. Nikander K. Adaptive aerosol delivery: the principles. Eur Respir Rev 1997;7:385-7.
56. Janssens HM, Krijgsman AM, Brown RJ, Verbraak AFM, de Jongste JC, Tiddens HAWM. Influence of tidal volume and respiratory rate on aerosol deposition in an infant upper airway model. Eur Respir J 1999;(Suppl 14)30:179.
57. Mellon M, Leflein J, Walton-Bowen K, Cruz-Rivera M, Fitzpatrick S, Smith JA. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am J Respir Crit Care Med 2000;162:593-8.
58. Janssens HM, van der Wiel EC, Verbraak AF, de Jongste JC, Merkus PJ, Tiddens HA. Aerosol therapy and the fighting toddler: is administration during sleep an alternative? J Aerosol Med 2003;16:395-400.
59. Kesser B, Geller D, Amirav I, Fink J. Baby don't cry: in vitro comparison of "baby's breath" aerosol delivery hood vs. Face mask or blow-by using the "saint" infant upper airway model and "aeroneb go" vs t-piece nebulizer. AARC 2003, convention proceedings abstract book page 17.